drugset / Trial / NCT02867098
XmAb5871 Bioavailability Study
Non-randomizedParallel-groupOpen-labelOther
Summary
An open label comparison of concentration of the study medication administered intravenously (IV) versus subcutaneously (SC) in healthy volunteers.
Timeline
- Start
- 2016-07
- Primary completion
- 2016-10-21
- Completion
- 2016-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Obexelimab | Monoclonal antibody | 125 mg | Subcutaneous |
| Subject | Obexelimab | Monoclonal antibody | 250 mg | Subcutaneous |
| Subject | Obexelimab | Monoclonal antibody | 375 mg | Subcutaneous |
Indications
No indication recorded.